Short answer
LIFECORE BIOMEDICAL, INC. DE (LFCR) filed an 8-K current report with the SEC on May 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q1 fiscal 2026 results for quarter ended March 31, 2026.
LIFECORE BIOMEDICAL, INC. DE 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 fiscal 2026 results for quarter ended March 31, 2026
- Press release furnished as Exhibit 99.1 with consolidated financial results
- Investor focus: review Exhibit 99.1 for revenue, profitability, liquidity, and outlook details
Item 7.01 · Regulation FD Disclosure
- Investor presentation published May 6, 2026 under Regulation FD
- Exhibit 99.2 contains the presentation and may include material investor updates
- Investors should review Exhibit 99.2 for disclosed strategy, operating metrics, and outlook information
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LIFECORE BIOMEDICAL, INC. DE 8-K filings
Get the next LFCR 8-K as it lands
Follow LFCR for push alerts, or ask the research agent what this filing means.